Home › Stocks › SYRE › All Fund Holders
SYRE — SPYRE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $3.55B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 13.03M | $1.16B | 0.06% | Add |
| BlackRock Inc history | Q2 2026 | 6.51M | $577.66M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 2.56M | $239.26M | 0.01% | Add |
| Capital World Investors history | Q2 2026 | 2.32M | $205.57M | 0.03% | Add |
| Bank of America Corp history | Q2 2026 | 1.78M | $157.84M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.58M | $140.41M | 0.03% | Reduce |
| Vanguard Group history | Q4 2025 | 4.04M | $132.19M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.48M | $131.22M | 0.04% | Add |
| Franklin Resources history | Q2 2026 | 1.47M | $130.77M | 0.03% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.09M | $98.87M | 0.01% | New |
| Marshall Wace history | Q2 2026 | 991.69K | $88.04M | 0.07% | Add |
| Janus Henderson Group history | Q1 2026 | 1.66M | $83.59M | 0.04% | Reduce |
| UBS Group AG history | Q2 2026 | 843.07K | $74.85M | 0.03% | Add |
| Northern Trust Corp history | Q2 2026 | 674.53K | $59.88M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 652.96K | $57.97M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 499.96K | $44.39M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 245.19K | $21.77M | 0.00% | Add |
| Point72 Asset Management history | Q4 2025 | 662.35K | $21.70M | 0.03% | New |
| Millennium Management history | Q2 2026 | 196.71K | $17.46M | 0.01% | Add |
| Farallon Capital Management history | Q2 2024 | 666.00K | $15.66M | 0.07% | Add |
| Deutsche Bank AG history | Q2 2026 | 174.46K | $15.49M | 0.01% | Add |
| Balyasny Asset Management history | Q2 2026 | 147.04K | $13.05M | 0.02% | Add |
| Invesco Ltd history | Q2 2026 | 120.54K | $10.70M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 104.52K | $9.28M | 0.01% | Reduce |
| Prudential Financial history | Q2 2026 | 87.37K | $7.76M | 0.01% | Add |
| Citigroup Inc history | Q2 2026 | 82.59K | $7.33M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 82.51K | $7.32M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 59.75K | $5.30M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 51.79K | $4.60M | 0.04% | New |
| Legal & General Investment Management America history | Q2 2026 | 49.14K | $4.36M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 26.45K | $2.35M | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 22.94K | $2.04M | 0.00% | Add |
| Soros Fund Management history | Q1 2025 | 125.00K | $2.02M | 0.03% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 70.84K | $1.67M | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 12.77K | $1.13M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 7.90K | $701.36K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2025 | 30.94K | $463.11K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 2.96M | $262.87K | 0.03% | Add |
| Amundi US history | Q2 2026 | 2.79K | $247.96K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 914 | $81.14K | 0.00% | Add |